The DOI matches its Crossref record; 150 of the 150 references it cites were found in a registry or an index.
Therapeutic bacteria to combat cancer; current advances, challenges, and opportunities
Open accessAbstract
Successful treatment of cancer remains a challenge, due to the unique pathophysiology of solid tumors, and the predictable emergence of resistance. Traditional methods for cancer therapy including radiotherapy, chemotherapy, and immunotherapy all have their own limitations. A novel approach is bacteriotherapy, either used alone, or in combination with conventional methods, has shown a positive effect on regression of tumors and inhibition of metastasis. Bacteria‐assisted tumor‐targeted therapy used as therapeutic/gene/drug delivery vehicles has great promise in the treatment of tumors. The use of bacteria only, or in combination with conventional methods was found to be effective in some experimental models of cancer (tumor regression and increased survival rate). In this article, we reviewed the major advantages, challenges, and prospective directions for combinations of bacteria with conventional methods for tumor therapy.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Bray, F., Ferlay, J., Soerjomataram, I., Siegel, R. L., Torre, L. A., & Jemal, A. (2018) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21492 · Cited by 84,109
Global cancer statistics, 2012
Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,850
An endotoxin-induced serum factor that causes necrosis of tumors
Carswell, E. A., Old, L. J., Kassel, R. L., Green, S., Fiore, N., & Williamson, B. (1975) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.72.9.3666 · Cited by 4,532
Nanoparticle-based theranostic agents
Xie, J., Lee, S., & Chen, X. (2010) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2010.07.009 · Cited by 1,422
Kay, A. B. (2001) · New England Journal of Medicine · doi:10.1056/nejm200101043440106 · Cited by 1,368
Gene therapy clinical trials worldwide to 2012 – an update
Ginn, S. L., Alexander, I. E., Edelstein, M. L., Abedi, M. R., & Wixon, J. (2013) · The Journal of Gene Medicine · doi:10.1002/jgm.2698 · Cited by 1,159
The global burden of cancer: priorities for prevention
Thun, M. J., DeLancey, J. O., Center, M. M., Jemal, A., & Ward, E. M. (2010) · Carcinogenesis · doi:10.1093/carcin/bgp263 · Cited by 1,091
Engineering the perfect (bacterial) cancer therapy
Forbes, N. S. (2010) · Nature Reviews Cancer · doi:10.1038/nrc2934 · Cited by 905
Gene therapy clinical trials worldwide to 2017: An update
Ginn, S. L., Amaya, A. K., Alexander, I. E., Edelstein, M., & Abedi, M. R. (2018) · The Journal of Gene Medicine · doi:10.1002/jgm.3015 · Cited by 903
Phase III Randomized Trial of Amifostine as a Radioprotector in Head and Neck Cancer
Brizel, D. M., Wasserman, T. H., Henke, M., Strnad, V., Rudat, V., Monnier, A., Eschwege, F., Zhang, J., Russell, L., Oster, W., et al. (2000) · Journal of Clinical Oncology · doi:10.1200/jco.2000.18.19.3339 · Cited by 828
Tumour-targeting bacteria engineered to fight cancer
Zhou, S., Gravekamp, C., Bermudes, D., & Liu, K. (2018) · Nature Reviews Cancer · doi:10.1038/s41568-018-0070-z · Cited by 821
An Agonist of Toll-Like Receptor 5 Has Radioprotective Activity in Mouse and Primate Models
Burdelya, L. G., Krivokrysenko, V. I., Tallant, T. C., Strom, E., Gleiberman, A. S., Gupta, D., Kurnasov, O. V., Fort, F. L., Osterman, A. L., DiDonato, J. A., et al. (2008) · Science · doi:10.1126/science.1154986 · Cited by 705
The role of the microbiome in cancer development and therapy
Bhatt, A. P., Redinbo, M. R., & Bultman, S. J. (2017) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21398 · Cited by 653
Toso, J. F. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.20.1.142 · Cited by 614
Datta, N. R., Ordóñez, S. G., Gaipl, U. S., Paulides, M. M., Crezee, H., Gellermann, J., Marder, D., Puric, E., & Bodis, S. (2015) · Cancer Treatment Reviews · doi:10.1016/j.ctrv.2015.05.009 · Cited by 588
Combination bacteriolytic therapy for the treatment of experimental tumors
Dang, L. H., Bettegowda, C., Huso, D. L., Kinzler, K. W., & Vogelstein, B. (2001) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.251543698 · Cited by 563
Tumor-targeted Salmonella as a novel anticancer vector.
Pawelek, J. M., Low, K. B., & Bermudes, D. G. (1997) · PubMed · Cited by 527
Vesicle-Mediated Export and Assembly of Pore-Forming Oligomers of the Enterobacterial ClyA Cytotoxin
Wai, S. N., Lindmark, B., Söderblom, T., Takade, A., Westermark, M., Oscarsson, J., Jass, J., Richter-Dahlfors, A., Mizunoe, Y., & Uhlin, B. E. (2003) · Cell · doi:10.1016/s0092-8674(03)00754-2 · Cited by 509
Zhao, M., Yang, M., Li, X.-M., Jiang, P., Baranov, E., Li, S., Xu, M., Penman, S., & Hoffman, R. M. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0408422102 · Cited by 484
Low, K. B., Ittensohn, M., Le, T., Platt, J., Sodi, S., Amoss, M., Ash, O., Carmichael, E., Chakraborty, A., Fischer, J., et al. (1999) · Nature Biotechnology · doi:10.1038/5205 · Cited by 476
Engineering bacteria for diagnostic and therapeutic applications
Riglar, D. T., & Silver, P. A. (2018) · Nature Reviews Microbiology · doi:10.1038/nrmicro.2017.172 · Cited by 460
Magnetic nanoparticle-based drug delivery for cancer therapy
Tietze, R., Zaloga, J., Unterweger, H., Lyer, S., Friedrich, R. P., Janko, C., Pöttler, M., Dürr, S., & Alexiou, C. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.08.022 · Cited by 425
Yu, Y. A., Shabahang, S., Timiryasova, T. M., Zhang, Q., Beltz, R., Gentschev, I., Goebel, W., & Szalay, A. A. (2004) · Nature Biotechnology · doi:10.1038/nbt937 · Cited by 423
Theranostic applications of nanoparticles in cancer
Ahmed, N., Fessi, H., & Elaissari, A. (2012) · Drug Discovery Today · doi:10.1016/j.drudis.2012.03.010 · Cited by 409
Österlund, P., Ruotsalainen, T., Korpela, R., Saxelin, M., Ollus, A., Valta, P., Kouri, M., Elomaa, I., & Joensuu, H. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603990 · Cited by 405
Impact of Tumor Hypoxia and Anemia on Radiation Therapy Outcomes
Harrison, L. B., Chadha, M., Hill, R. J., Hu, K., & Shasha, D. (2002) · The Oncologist · doi:10.1634/theoncologist.7-6-492 · Cited by 376
Two EGF molecules contribute additively to stabilization of the EGFR dimer
Lemmon, M. A. (1997) · The EMBO Journal · doi:10.1093/emboj/16.2.281 · Cited by 367
Biogenic gas nanostructures as ultrasonic molecular reporters
Shapiro, M. G., Goodwill, P. W., Neogy, A., Yin, M., Foster, F. S., Schaffer, D. V., & Conolly, S. M. (2014) · Nature Nanotechnology · doi:10.1038/nnano.2014.32 · Cited by 367
Wachsberger, P. R., Burd, R., & Dicker, A. P. (2003) · PubMed · Cited by 358
Tumor hypoxia: A target for selective cancer therapy
Kizaka‐Kondoh, S., Inoue, M., Harada, H., & Hiraoka, M. (2003) · Cancer Science · doi:10.1111/j.1349-7006.2003.tb01395.x · Cited by 352
Nemunaitis, J., Cunningham, C., Senzer, N., Kuhn, J., Cramm, J., Litz, C., Cavagnolo, R., Cahill, A., Clairmont, C., & Sznol, M. (2003) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700634 · Cited by 341
Bacteria in cancer therapy: a novel experimental strategy
Patyar, S., Joshi, R., Byrav, D. P., Prakash, A., Medhi, B., & Das, B. (2010) · Journal of Biomedical Science · doi:10.1186/1423-0127-17-21 · Cited by 340
Distribution, formation and regulation of gas vesicles
Pfeifer, F. (2012) · Nature Reviews Microbiology · doi:10.1038/nrmicro2834 · Cited by 328
Optically-controlled bacterial metabolite for cancer therapy
Zheng, D.-W., Chen, Y., Li, Z.-H., Xu, L., Li, C.-X., Li, B., Fan, J.-X., Cheng, S.-X., & Zhang, X.-Z. (2018) · Nature Communications · doi:10.1038/s41467-018-03233-9 · Cited by 324
Use of probiotics for prevention of radiation-induced diarrhea
Delia, P. (2007) · World Journal of Gastroenterology · doi:10.3748/wjg.v13.i6.912 · Cited by 311
Bacteriolytic therapy can generate a potent immune response against experimental tumors
Agrawal, N., Bettegowda, C., Cheong, I., Geschwind, J.-F., Drake, C. G., Hipkiss, E. L., Tatsumi, M., Dang, L. H., Diaz, L. A., Pomper, M., et al. (2004) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0406242101 · Cited by 304
Engineered commensal microbes for diet-mediated colorectal-cancer chemoprevention
Ho, C. L., Tan, H. Q., Chua, K. J., Kang, A., Lim, K. H., Ling, K. L., Yew, W. S., Lee, Y. S., Thiery, J. P., & Chang, M. W. (2018) · Nature Biomedical Engineering · doi:10.1038/s41551-017-0181-y · Cited by 303
A Hybrid Vector for Ligand-Directed Tumor Targeting and Molecular Imaging
Hajitou, A., Trepel, M., Lilley, C. E., Soghomonyan, S., Alauddin, M. M., Marini, F. C., Restel, B. H., Ozawa, M. G., Moya, C. A., Rangel, R., et al. (2006) · Cell · doi:10.1016/j.cell.2006.02.042 · Cited by 280
Strategies for enzyme/prodrug cancer therapy.
Xu, G., & McLeod, H. L. (2001) · PubMed · Cited by 279
Malmgren, R. A., & Flanigan, C. (1955) · PubMed · Cited by 263
Kominsky, S. L., Vali, M., Korz, D., Gabig, T. G., Weitzman, S. A., Argani, P., & Sukumar, S. (2004) · The American Journal of Pathology · doi:10.1016/s0002-9440(10)63721-2 · Cited by 263
Bacteria-Mediated Hypoxia-Specific Delivery of Nanoparticles for Tumors Imaging and Therapy
Luo, C.-H., Huang, C.-T., Su, C.-H., & Yeh, C.-S. (2016) · Nano Letters · doi:10.1021/acs.nanolett.6b00262 · Cited by 256
Chitapanarux, I., Chitapanarux, T., Traisathit, P., Kudumpee, S., Tharavichitkul, E., & Lorvidhaya, V. (2010) · Radiation Oncology · doi:10.1186/1748-717x-5-31 · Cited by 254
Cyclomodulins: bacterial effectors that modulate the eukaryotic cell cycle
Nougayrède, J.-P., Taieb, F., Rycke, J. D., & Oswald, E. (2005) · Trends in Microbiology · doi:10.1016/j.tim.2005.01.002 · Cited by 249
Prodrug-activating systems in suicide gene therapy
Springer, C. J., & Niculescu-Duvaz, I. (2000) · Journal of Clinical Investigation · doi:10.1172/jci10001 · Cited by 229
Jiang, S.-N., Phan, T. X., Nam, T.-K., Nguyen, V. H., Kim, H.-S., Bom, H.-S., Choy, H. E., Hong, Y., & Min, J.-J. (2010) · Molecular Therapy · doi:10.1038/mt.2009.295 · Cited by 226
Bacterial infection as a cause of cancer.
Parsonnet, J. (1995) · Environmental Health Perspectives · doi:10.1289/ehp.95103s8263 · Cited by 221
Microbubble-mediated ultrasound therapy: a review of its potential in cancer treatment
Ibsen, S., Schutt, & Esener (2013) · Drug Design, Development and Therapy · doi:10.2147/dddt.s31564 · Cited by 219
Genetically Engineered Salmonella typhimurium as an Imageable Therapeutic Probe for Cancer
Nguyen, V. H., Kim, H.-S., Ha, J.-M., Hong, Y., Choy, H. E., & Min, J.-J. (2010) · Cancer Research · doi:10.1158/0008-5472.can-09-3453 · Cited by 214
Salmonella typhimurium specifically chemotax and proliferate in heterogeneous tumor tissue in vitro
Kasinskas, R. W., & Forbes, N. S. (2006) · Biotechnology and Bioengineering · doi:10.1002/bit.20883 · Cited by 209
VSL#3 probiotic treatment reduces chemotherapy-induced diarrhoea and weight loss
Bowen, J. M., Stringer, A. M., Gibson, R. J., Yeoh, A. S., Hannam, S., & Keefe, D. M. (2007) · Cancer Biology & Therapy · doi:10.4161/cbt.6.9.4622 · Cited by 202
Modulating tumor hypoxia by nanomedicine for effective cancer therapy
Jahanban‐Esfahlan, R., de la Guardia, M., Ahmadi, D., & Yousefi, B. (2018) · Journal of Cellular Physiology · doi:10.1002/jcp.25859 · Cited by 201
Minton, N. P. (2003) · Nature Reviews Microbiology · doi:10.1038/nrmicro777 · Cited by 192
Bacterial delivery of a novel cytolysin to hypoxic areas of solid tumors
Ryan, R. M., Green, J., Williams, P. J., Tazzyman, S., Hunt, S., Harmey, J. H., Kehoe, S. C., & Lewis, C. E. (2009) · Gene Therapy · doi:10.1038/gt.2008.188 · Cited by 191
Oswald, E., Sugai, M., Labigne, A., Wu, H. C., Fiorentini, C., Boquet, P., & O'Brien, A. D. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.9.3814 · Cited by 191
Nontoxic radioactive Listeria at is a highly effective therapy against metastatic pancreatic cancer
Quispe-Tintaya, W., Chandra, D., Jahangir, A., Harris, M., Casadevall, A., Dadachova, E., & Gravekamp, C. (2013) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1211287110 · Cited by 186
Induction of potent antitumor immunity by in situ targeting of intratumoral DCs
Furumoto, K., Soares, L., Engleman, E. G., & Merad, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci19762 · Cited by 184
Cancer Immunotherapy Based on Killing of Salmonella -Infected Tumor Cells
Avogadri, F., Martinoli, C., Petrovska, L., Chiodoni, C., Transidico, P., Bronte, V., Longhi, R., Colombo, M. P., Dougan, G., & Rescigno, M. (2005) · Cancer Research · doi:10.1158/0008-5472.can-04-3002 · Cited by 181
Zurkiya, O., Chan, A. W. S., & Hu, X. (2008) · Magnetic Resonance in Medicine · doi:10.1002/mrm.21606 · Cited by 181
Induction of potent antitumor immunity by in situ targeting of intratumoral DCs
Furumoto, K., Soares, L., Engleman, E. G., & Merad, M. (2004) · Journal of Clinical Investigation · doi:10.1172/jci200419762 · Cited by 180
Sharma, A., Rath, G. K., Chaudhary, S. P., Thakar, A., Mohanti, B. K., & Bahadur, S. (2012) · European Journal of Cancer · doi:10.1016/j.ejca.2011.06.010 · Cited by 179
Giralt, J., Regadera, J. P., Verges, R., Romero, J., de la Fuente, I., Biete, A., Villoria, J., Cobo, J. M., & Guarner, F. (2008) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2007.11.009 · Cited by 179
Ganai, S., Arenas, R. B., & Forbes, N. S. (2009) · British Journal of Cancer · doi:10.1038/sj.bjc.6605403 · Cited by 179
Heimann, D. M., & Rosenberg, S. A. (2003) · Journal of Immunotherapy · doi:10.1097/00002371-200303000-00011 · Cited by 177
Thamm, D. H., Kurzman, I. D., King, I., Li, Z., Sznol, M., Dubielzig, R. R., Vail, D. M., & MacEwen, E. G. (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-04-2510 · Cited by 174
Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteria
Bettegowda, C., Dang, L. H., Abrams, R., Huso, D. L., Dillehay, L., Cheong, I., Agrawal, N., Borzillary, S., McCaffery, J. M., Watson, E. L., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2036598100 · Cited by 172
Quantitative bioluminescence imaging of tumor-targeting bacteria in living animals
Min, J.-J., Nguyen, V. H., Kim, H.-J., Hong, Y., & Choy, H. E. (2008) · Nature Protocols · doi:10.1038/nprot.2008.32 · Cited by 170
A Bacterial Protein Enhances the Release and Efficacy of Liposomal Cancer Drugs
Cheong, I., Huang, X., Bettegowda, C., Diaz, L. A., Kinzler, K. W., Zhou, S., & Vogelstein, B. (2006) · Science · doi:10.1126/science.1130651 · Cited by 168
Adjunctive Treatments for the Prevention of Chemotherapy- and Radiotherapy-Induced Mucositis
Thomsen, M., & Vitetta, L. (2018) · Integrative Cancer Therapies · doi:10.1177/1534735418794885 · Cited by 168
Yazawa, K., Fujimori, M., Nakamura, T., Sasaki, T., Amano, J., Kano, Y., & Taniguchi, S. (2001) · Breast Cancer Research and Treatment · doi:10.1023/a:1010644217648 · Cited by 161
The role of bacteria in cancer therapy – enemies in the past, but allies at present
Song, S., Vuai, M. S., & Zhong, M. (2018) · Infectious Agents and Cancer · doi:10.1186/s13027-018-0180-y · Cited by 160
Nanoparticles for cancer gene therapy: Recent advances, challenges, and strategies
Wang, K., Kievit, F. M., & Zhang, M. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.10.016 · Cited by 158
Chang (2018) · doi:10.3389/fmicb.2018.00983 · Cited by 152
Repopulation of tumour cells between cycles of chemotherapy: a neglected factor
Davis, A. J., & Tannock, I. F. (2000) · The Lancet Oncology · doi:10.1016/s1470-2045(00)00019-x · Cited by 151
Bacterial Therapy of Cancer: Promises, Limitations, and Insights for Future Directions
Kramer, M. G., Masner, M., Ferreira, F. A., & Hoffman, R. M. (2018) · Frontiers in Microbiology · doi:10.3389/fmicb.2018.00016 · Cited by 145
Theys, J., Pennington, O. J., Dubois, L. J., Anlezark, G., Vaughan, T. E., Mengesha, A., Landuyt, W., Anné, J., Burke, P. J., Dürre, P., et al. (2006) · British Journal of Cancer · doi:10.1038/sj.bjc.6603367 · Cited by 135
Yam, C., Zhao, M. D., Hayashi, K., et al. (2009) · Journal of Surgical Research · doi:10.1016/j.jss.2009.02.023 · Cited by 134
Visualizing Implanted Tumors in Mice with Magnetic Resonance Imaging Using Magnetotactic Bacteria
Benoit, M. R., Mayer, D., Barak, Y., Chen, I. Y., Hu, W., Cheng, Z., Wang, S. X., Spielman, D. M., Gambhir, S. S., & Matin, A. (2009) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-08-3206 · Cited by 131
Delia, P., Sansotta, G., Donato, V., Messina, G., Frosina, P., Pergolizzi, S., Renzis, C. D., & Famularo, G. (2002) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2002.05946.x · Cited by 128
Pharmacologic and Toxicologic Evaluation of C. novyi-NT Spores
Diaz, L. A., Cheong, I., Foss, C. A., Zhang, X., Peters, B. A., Agrawal, N., Bettegowda, C., Karim, B. O., Liu, G., Khan, K., et al. (2005) · Toxicological Sciences · doi:10.1093/toxsci/kfi316 · Cited by 117
Wei, M. Q., Ellem, K. A. O., Dunn, P., West, M., Bai, C. X., & Vogelstein, B. (2006) · European Journal of Cancer · doi:10.1016/j.ejca.2006.10.005 · Cited by 117
Probiotic bacteria in cancer patients undergoing chemotherapy and radiation therapy
Mego, M., Holec, V., Drgona, L., Hainova, K., Ciernikova, S., & Zajac, V. (2013) · Complementary Therapies in Medicine · doi:10.1016/j.ctim.2013.08.018 · Cited by 112
Wei, D., Heus, P., van de Wetering, F. T., van Tienhoven, G., Verleye, L., & Scholten, R. J. P. M. (2018) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd008831.pub3 · Cited by 108
Min, J., Kim, H., Park, J. H., Moon, S., Jeong, J., Hong, Y.-J., Cho, K., Nam, J. H., Kim, N., Park, Y., et al. (2007) · Molecular Imaging and Biology · doi:10.1007/s11307-007-0120-5 · Cited by 107
Nuyts, S., Mellaert, L. V., Theys, J., Landuyt, W., Bosmans, E., Anné, J., & Lambin, P. (2001) · Gene Therapy · doi:10.1038/sj.gt.3301499 · Cited by 106
Specific targeting of cytosine deaminase to solid tumors by engineered Clostridium acetobutylicum
Theys, J., Landuyt, W., Nuyts, S., Mellaert, L. V., van Oosterom, A., Lambin, P., & Anné, J. (2001) · Cancer Gene Therapy · doi:10.1038/sj.cgt.7700303 · Cited by 106
Evrard, A., Cuq, P., Ciccolini, J., Vian, L., & Cano, J. P. (1999) · British Journal of Cancer · doi:10.1038/sj.bjc.6690589 · Cited by 105
Clostridium spores as anti-tumour agents
Van Mellaert, L., Barbé, S., & Anné, J. (2006) · Trends in Microbiology · doi:10.1016/j.tim.2006.02.002 · Cited by 101
Pharmacological inhibitors of autophagy as novel cancer therapeutic agents
Wang, C., Hu, Q., & Shen, H. (2016) · Pharmacological Research · doi:10.1016/j.phrs.2016.01.028 · Cited by 100
Targeted Cancer Therapy Using EngineeredSalmonella typhimurium
Zheng, J. H., & Min, J.-J. (2016) · Chonnam Medical Journal · doi:10.4068/cmj.2016.52.3.173 · Cited by 100
Novel cancer vaccine based on genes of Salmonella pathogenicity island 2
Xiong, G., Husseiny, M. I., Song, L., Erdreich‐Epstein, A., Shackleford, G. M., Seeger, R. C., Jäckel, D., Hensel, M., & Metelitsa, L. S. (2009) · International Journal of Cancer · doi:10.1002/ijc.24957 · Cited by 98
Bacterial Toxins for Cancer Therapy
Zahaf, N.-I., & Schmidt, G. (2017) · Toxins · doi:10.3390/toxins9080236 · Cited by 98
Targeting Vascular and Avascular Compartments of Tumors withC. novyi-NTand Anti-microtubule Agents
Dang, L. H., Bettegowda, C., Agrawal, N., Cheong, I., Huso, D. L., Frost, P., Loganzo, F., Greenberger, L. M., Barkóczy, J., Pettit, G. R., et al. (2004) · Cancer Biology & Therapy · doi:10.4161/cbt.3.3.704 · Cited by 97
Fehleisen, N. (1882) · DMW - Deutsche Medizinische Wochenschrift · doi:10.1055/s-0029-1196806 · Cited by 96
Flentie, K., Kocher, B. A., Gammon, S. T., Novack, D. V., McKinney, J. S., & Piwnica-Worms, D. R. (2012) · Cancer Discovery · doi:10.1158/2159-8290.cd-11-0201 · Cited by 93
Fiorentini, C., Matarrese, P., Straface, E., Falzano, L., Fabbri, A., Donelli, G., Cossarizza, A., Boquet, P., & Malorni, W. (1998) · Experimental Cell Research · doi:10.1006/excr.1998.4057 · Cited by 90
Targeting solid tumors with non‐pathogenic obligate anaerobic bacteria
Taniguchi, S., Fujimori, M., Sasaki, T., Tsutsui, H., Shimatani, Y., Seki, K., & Amano, J. (2010) · Cancer Science · doi:10.1111/j.1349-7006.2010.01628.x · Cited by 89
Bacteria and genetically modified bacteria as cancer therapeutics: Current advances and challenges
Nallar, S. C., Xu, D.-Q., & Kalvakolanu, D. V. (2016) · Cytokine · doi:10.1016/j.cyto.2016.01.002 · Cited by 89
Lee, C., Wu, C., Tai, Y., & Shiau, A. (2005) · Molecular Therapy · doi:10.1016/j.ymthe.2005.01.008 · Cited by 83
Weill, F. S., Eliana, M., Paz, M. L., Ferrari, A., Leoni, J., & Maglio, D. H. G. (2012) · British Journal Of Nutrition · doi:10.1017/s0007114512001225 · Cited by 82
Barbé, S., Mellaert, L. V., Theys, J., Geukens, N., Lammertyn, E., Lambin, P., & Anné, J. (2005) · FEMS Microbiology Letters · doi:10.1016/j.femsle.2005.03.037 · Cited by 79
Delivery of protein to the cytosol of macrophages using Escherichia coli K‐12
Higgins, D. E., Shastri, N., & Portnoy, D. A. (1999) · Molecular Microbiology · doi:10.1046/j.1365-2958.1999.01272.x · Cited by 79
Gastrointestinal flora and its alterations in critical illness
Marshall, J. C. (1999) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/00075197-199909000-00009 · Cited by 74
Whitford, E. J., Cummins, A. G., Butler, R. N., Prisciandaro, L. D., Fauser, J. K., Yazbeck, R., Lawrence, A. J., Cheah, K. Y., Wright, T. H., Lymn, K. A., et al. (2009) · Cancer Biology & Therapy · doi:10.4161/cbt.8.6.7594 · Cited by 73
Theys, J., Nuyts, S., Landuyt, W., Mellaert, L. V., Dillen, C., Böhringer, M., Dürre, P., Lambin, P., & Anné, J. (1999) · Applied and Environmental Microbiology · doi:10.1128/aem.65.10.4295-4300.1999 · Cited by 70
Nuyts, S., Mellaert, L. V., Theys, J., Landuyt, W., Lambin, P., & Anné, J. (2001) · Radiation Research · doi:10.1667/0033-7587(2001)155[0716:tuorib]2.0.co;2 · Cited by 69
Tjuvajev, J., Blasberg, R. G., Luo, X., Zheng, L., King, I., & Bermudes, D. G. (2001) · Journal of Controlled Release · doi:10.1016/s0168-3659(01)00340-6 · Cited by 68
Effects of probiotics on radiation-induced intestinal injury in rats
Demirer, S., Aydıntuğ, S., Aslım, B., Kepenekçi, İ., Şengül, N., Evirgen, O., Gerçeker, D., Andrıeu, M. N., Ulusoy, C., & Karahüseyinoğlu, S. (2006) · Nutrition · doi:10.1016/j.nut.2005.08.003 · Cited by 68
Felgner, S., Kocijancic, D., Frahm, M., Heise, U., Rohde, M., Zimmermann, K., Falk, C. S., Erhardt, M., & Weiß, S. (2017) · OncoImmunology · doi:10.1080/2162402x.2017.1382791 · Cited by 67
Antitumour effects of genetically engineered Salmonella in combination with radiation
Platt, J. T., Sodi, S., Kelley, M., Rockwell, S., Bermudes, D. G., Low, K. B., & Pawelek, J. M. (2000) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00336-1 · Cited by 66
Advancing Cancer Therapy with Present and Emerging Immuno-Oncology Approaches
Kamta, J., Chaar, M., Ande, A., Altomare, D. A., & Ait‐Oudhia, S. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00064 · Cited by 65
Jia, L., Wei, D., Sun, Q., Jin, G., Li, S., Huang, Y., & Hua, Z. (2007) · International Journal of Cancer · doi:10.1002/ijc.22688 · Cited by 64
Live bacteria as anticancer agents and tumor-selective protein delivery vectors.
Bermudes, D. G., Zheng, L.-M., & King, I. (2002) · PubMed · Cited by 63
Oral delivery of tumor‐targeting Salmonella for cancer therapy in murine tumor models
Jia, L., Wei, D., Sun, Q., Huang, Y., Wu, Q., & Hua, Z. (2007) · Cancer Science · doi:10.1111/j.1349-7006.2007.00503.x · Cited by 61
Potential and limitations of bacterial-mediated cancer therapy
Mengesha, A. (2007) · Frontiers in bioscience · doi:10.2741/2357 · Cited by 59
Intratumoural production of TNFα by bacteria mediates cancer therapy
Murphy, C., Rettedal, E. A., Lehouritis, P., Devoy, C., & Tangney, M. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180034 · Cited by 58
Functional antibodies produced by oncolytic clostridia
Groot, A. J., Mengesha, A., van der Wall, E., van Diest, P. J., Theys, J., & Vooijs, M. (2007) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2007.10.126 · Cited by 57
Salmonella-Mediated Cancer Therapy: Roles and Potential
Nguyen, V. H., & Min, J. (2016) · Nuclear Medicine and Molecular Imaging · doi:10.1007/s13139-016-0415-z · Cited by 53
The Function of Gas Vesicles in Halophilic Archaea and Bacteria: Theories and Experimental Evidence
Oren, A. (2012) · Life · doi:10.3390/life3010001 · Cited by 50
Nuyts, S., Theys, J., Landuyt, W., Mellaert, L. V., Lambin, P., & Anné, J. (2001) · PubMed · Cited by 48
Whole-body imaging of bacterial infection and antibiotic response
Hoffman, R. M., & Zhao, M. D. (2006) · Nature Protocols · doi:10.1038/nprot.2006.376 · Cited by 47
(1929) · The Lancet · doi:10.1016/s0140-6736(00)85401-x · Cited by 47
Use of Probiotics in the Management of Chemotherapy‐Induced Diarrhea: A Case Study
El‐Atti, S. A., Wasicek, K., Mark, S. M., et al. (2009) · Journal of Parenteral and Enteral Nutrition · doi:10.1177/0148607109332004 · Cited by 46
Use of botulinum toxins in cancer therapy
Ansiaux, R., & Gallez, B. (2007) · Expert Opinion on Investigational Drugs · doi:10.1517/13543784.16.2.209 · Cited by 43
Ki, Y., Kim, W., Cho, H., Ahn, K., Choi, Y., & Kim, D. (2014) · Journal of Korean Medical Science · doi:10.3346/jkms.2014.29.10.1372 · Cited by 42
Tumour‐targeting bacteria‐based cancer therapies for increased specificity and improved outcome
Felgner, S., Pawar, V., Kocijancic, D., Erhardt, M., & Weiß, S. (2017) · Microbial Biotechnology · doi:10.1111/1751-7915.12787 · Cited by 41
Dresselaers, T., Theys, J., Nuyts, S., Wouters, B. G., de Bruijn, E. A., Anné, J., Lambin, P., Hecke, P. V., & Landuyt, W. (2003) · British Journal of Cancer · doi:10.1038/sj.bjc.6601345 · Cited by 38
Falnes, P. Ø., Ariansen, S. L., Sandvig, K., & Olsnes, S. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.6.4363 · Cited by 36
Perspectives in vector development for systemic cancer gene therapy.
Hatefi, A., & Canine, B. (2009) · PubMed · Cited by 35
Optimization of tumor-targeted gene delivery by engineered attenuated Salmonella typhimurium.
Mei, S., Theys, J., Landuyt, W., Anné, J., & Lambin, P. (2002) · PubMed · Cited by 32
Tumor Physiology and Resistance to Chemotherapy: Repopulation and Drug Penetration
Davis, A. J., & Tannock, I. F. (2002) · Cancer treatment and research · doi:10.1007/978-1-4615-1173-1_1 · Cited by 29
Clostridium to treat cancer: dream or reality?
Theys, J., & Lambin, P. (2015) · PubMed Central · doi:10.3978/j.issn.2305-5839.2015.03.39 · Cited by 28
Probiotics for Rectal Volume Variation During Radiation Therapy for Prostate Cancer
Ki, Y., Kim, W., Nam, J., Kim, D., Lee, J. M., Park, D., Jeon, H., Ha, H. G., Kim, T., & Kim, D. (2013) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/j.ijrobp.2013.07.038 · Cited by 27
A review of chemoprophylaxis and therapy of bacterial infections in neutropenic patients
Klastersky, J. A. (1989) · Diagnostic Microbiology and Infectious Disease · doi:10.1016/0732-8893(89)90137-5 · Cited by 23
Bioengineered Colorectal Cancer Drugs: Orally Delivered Anti-Inflammatory Agents
Urbanska, A. M., Zhang, X., & Prakash, S. (2015) · Cell Biochemistry and Biophysics · doi:10.1007/s12013-015-0528-5 · Cited by 22
Gastrointestinal flora and its alterations in critical illness
Marshall, J. C. (1999) · Current Opinion in Critical Care · doi:10.1097/00075198-199904000-00005 · Cited by 22
He, J., Wang, W.-Z., Qi, H., Ma, Y., & He, S. (2018) · Medical Hypotheses · doi:10.1016/j.mehy.2018.07.024 · Cited by 16
Safety and efficacy of primary thromboprophylaxis in cancer patients
Escobar, I. G., Rebollo, M. T. A., Adrián, S. G., Garzotto, A. A. R., & Martín, A. J. M. (2016) · Clinical & Translational Oncology · doi:10.1007/s12094-016-1500-6 · Cited by 15
The potential roles of bacteria to improve radiation treatment outcome
Kouhsari, E., Ghadimi‐Daresajini, A., Abdollahi, H., Amirmozafari, N., Mahdavi, S. R., Abbasian, S., Mousavi, S. H., Yaseri, H. F., & Moghaderi, M. (2017) · Clinical & Translational Oncology · doi:10.1007/s12094-017-1701-7 · Cited by 15
Self-citationProbiotic-based protection of normal tissues during radiotherapy
Abdollahi, H. (2014) · Nutrition · doi:10.1016/j.nut.2013.09.006 · Cited by 14
Dubois, L. J., Dresselaers, T., Landuyt, W., Paesmans, K., Mengesha, A., Wouters, B. G., Hecke, P. V., Theys, J., & Lambin, P. (2007) · British Journal of Cancer · doi:10.1038/sj.bjc.6603624 · Cited by 14
Further progress with oncolysis due to apathogenic clostridia.
Gericke, D., Dietzel, F., König, W., Rüster, I., & Schumacher, L. (1979) · PubMed · Cited by 14
[Tumor hyperthermia using high frequency for increase of oncolysis by clostridium butyricum (M 55)].
Dietzel, F., Gericke, D., & König, W. (1976) · PubMed · Cited by 13
Role of nontoxigenic Clostridium novyi in solid tumor therapy
Zhang, S., Chen, Y., Wang, J., Tang, F., Miao, T., & Li, M. (2014) · Reviews in Medical Microbiology · doi:10.1097/mrm.0000000000000005 · Cited by 11
Dietzel, F., & Gericke, D. (1977) · PubMed · Cited by 11
New therapeutics from Nature: The odd case of the bacterial cytotoxic necrotizing factor 1
Maroccia, Z., Loizzo, S., Travaglione, S., Frank, C., Fabbri, A., & Fiorentini, C. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.02.140 · Cited by 11
The potential use of biogas producing microorganisms in radiation protection
Abdollahi, H., Atashzar, M. R., & Amini, M. (2015) · Journal of Medical Hypotheses and Ideas · doi:10.1016/j.jmhi.2015.04.001 · Cited by 10
Application of hydrogen producing microorganisms in radiotherapy: an idea.
Khademi, S., & Abdollahi, H. (2014) · PubMed · Cited by 9
Abdollahi, H. (2015) · Medical Hypotheses · doi:10.1016/j.mehy.2014.12.021 · Cited by 8
Marth, E., & Möse, J. R. (1987) · Zentralblatt für Bakteriologie Mikrobiologie und Hygiene Series A Medical Microbiology Infectious Diseases Virology Parasitology · doi:10.1016/s0176-6724(87)80150-5 · Cited by 7
Cited by
Targeting the gut and tumor microbiota in cancer
Park, E. M., Chelvanambi, M., Bhutiani, N., Kroemer, G., Zitvogel, L., & Wargo, J. A. (2022) · Nature Medicine · doi:10.1038/s41591-022-01779-2 · Cited by 496
Engineering microrobots for targeted cancer therapies from a medical perspective
Schmidt, C. K., Medina-Sánchez, M., Edmondson, R. J., & Schmidt, O. G. (2020) · Nature Communications · doi:10.1038/s41467-020-19322-7 · Cited by 441
Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles
Souri, M., Soltani, M., Moradi Kashkooli, F., & Kiani Shahvandi, M. (2022) · Journal of Controlled Release · doi:10.1016/j.jconrel.2021.11.024 · Cited by 178
Genetically Engineered Microorganisms and Their Impact on Human Health
Mahdizade Ari, M., Dadgar, L., Elahi, Z., Ghanavati, R., & Taheri, B. (2024) · International Journal of Clinical Practice · doi:10.1155/2024/6638269 · Cited by 67
Do Bacteria Provide an Alternative to Cancer Treatment and What Role Does Lactic Acid Bacteria Play?
Dicks, L. M. T., & Vermeulen, W. (2022) · Microorganisms · doi:10.3390/microorganisms10091733 · Cited by 25
Metadata
- Authors
- Sedighi, M., Zahedi Bialvaei, A., Hamblin, M. R., Ohadi, E., Asadi, A., Halajzadeh, M., Lohrasbi, V., Mohammadzadeh, N., Amiriani, T., Krutova, M., Amini, A., & Kouhsari, E.
- Venue
- Cancer Medicine
- Publisher
- Wiley
- Published
- 2019-04-05
- Volume
- 8
- Issue
- 6
- Pages
- 3167-3181
- ISSN
- 2045-7634 (ISSN-L)
- OpenAlex
- W2925402322
- Cited by
- 308
- References
- 150
- FWCI
- 16.87
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.